Similarly, MECP2, a transcriptional modulator that binds methylated DNA, primarily known for its role in Rett syndrome, is generally overexpressed in many cancers, although its role in leukemia remains underexplored [48,49]. This evidence concerns the gene MECP2 and atypical Rett syndrome.